Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Plus Therapeutics (PSTV) Goodwill & Intangibles (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Goodwill & Intangibles for 16 consecutive years, with $746000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 15.71% to $746000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $746000.0, a 15.71% decrease, with the full-year FY2024 number at $841000.0, up 103.14% from a year prior.
  • Goodwill & Intangibles was $746000.0 for Q3 2025 at Plus Therapeutics, down from $773000.0 in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $929000.0 in Q2 2024 to a low of $405000.0 in Q1 2024.
  • A 5-year average of $578111.1 and a median of $475500.0 in 2022 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: skyrocketed 113.07% in 2024, then fell 16.79% in 2025.
  • Plus Therapeutics' Goodwill & Intangibles stood at $432000.0 in 2021, then grew by 7.87% to $466000.0 in 2022, then decreased by 11.16% to $414000.0 in 2023, then surged by 103.14% to $841000.0 in 2024, then decreased by 11.3% to $746000.0 in 2025.
  • Per Business Quant, the three most recent readings for PSTV's Goodwill & Intangibles are $746000.0 (Q3 2025), $773000.0 (Q2 2025), and $807000.0 (Q1 2025).